FACT (FACT II Acquisition Corp. Class A Ordinary Shares)
Insider Trading Activity
Every open-market purchase and sale reported by FACT officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2010-04-21 | Maninder Hora | VP, Prod Ops. & Quality | U | — | — |
| 2010-04-21 | KURT VON EMSTER | Director | U | — | — |
| 2010-04-21 | GARY A LYONS | Director | U | — | — |
| 2010-04-21 | Ted Llana | SVP Comm'l & Corp. Dev | U | — | — |
| 2010-04-21 | HERB CROSS | VP of Finance/Prin Acctg Off | U | — | — |
| 2010-04-21 | Bradford S Goodwin | Director | U | — | — |
| 2010-04-21 | BAUPOST GROUP LLC/MA | 10%+ Owner | U | — | — |
| 2010-04-21 | ANDREW GUGGENHIME | SVP & CFO | U | — | — |
| 2010-04-21 | Francis Willard Sarena | VP Gen Counsel & Secy | U | — | — |
| 2010-04-21 | Faheem Hasnain | President & CEO | U | — | — |
| 2010-04-21 | Mark Rolfe | Sr. Vice Pres. and CSO | U | — | — |
| 2010-04-21 | David Ross Parkinson | Director | U | — | — |
| 2010-04-21 | Amber Acquisition Inc. | 10%+ Owner | MIXED | — | — |
| 2010-04-12 | SAK CORP | 10%+ Owner | Sell | — | — |
| 2010-04-05 | ANDREW GUGGENHIME | SVP & CFO | F | — | — |
| 2010-03-17 | SAK CORP | 10%+ Owner | Sell | — | — |
| 2010-02-09 | BIOTECHNOLOGY VALUE FUND L P | — | Buy | — | — |
| 2010-02-04 | BVF INVESTMENTS LLC | — | Buy | — | — |
| 2010-01-29 | BVF INVESTMENTS LLC | — | Buy | — | — |
| 2010-01-25 | HERB CROSS | Corp Controller/Prin Acctg Off | F | — | — |
| 2010-01-22 | Ted Llana | SVP Commercial & Corporate Dev | F | — | — |
| 2009-12-22 | HERB CROSS | Corp Controller/Prin Acctg Off | F | — | — |
| 2009-10-05 | Faheem Hasnain | President & CEO | F | — | — |
| 2009-09-22 | Ted Llana | SVP, Comm'l & Corp. Dev. | A | — | — |
| 2009-09-15 | Francis Willard Sarena | VP, Gen Counsel & Secy | F | — | — |
| 2009-09-15 | HERB CROSS | Corp Controller/Prin Acctg Off | F | — | — |
| 2009-09-09 | Hoyoung Huh | Director | A | — | — |
| 2009-09-08 | SETH A KLARMAN | 10%+ Owner | Sell | — | — |
| 2009-08-20 | Mark Rolfe | Sr. Vice Pres. and CSO | A | — | — |
| 2009-08-10 | ANDREW GUGGENHIME | SVP & CFO | A | — | — |
| 2009-08-10 | Ted Llana | SVP, Comm'l & Corp. Dev. | A | — | — |
| 2009-08-10 | Faheem Hasnain | President & CEO | A | — | — |
| 2009-08-10 | Maninder Hora | VP, Prod. Ops. & Quality | A | — | — |
| 2009-08-10 | Francis Willard Sarena | VP, Gen Counsel & Secy | A | — | — |
| 2009-08-10 | HERB CROSS | Corp Controller/Prin Acctg Off | A | — | — |
| 2009-07-28 | Maninder Hora | VP Product Operations & Quali | F | — | — |
| 2009-05-28 | Bradford S Goodwin | Director | A | — | — |
| 2009-05-28 | David Ross Parkinson | Director | A | — | — |
| 2009-05-28 | KURT VON EMSTER | Director | A | — | — |
| 2009-05-28 | GARY A LYONS | Director | A | — | — |
| 2009-04-06 | HERB CROSS | Corp Controller/Prin Acctg Off | A | — | — |
| 2009-04-06 | Mark Anthony McCamish | Sr. VP & Chief Medical Officer | A | — | — |
| 2009-04-06 | ANDREW GUGGENHIME | SVP & CFO | D | — | — |
| 2009-04-06 | Francis Willard Sarena | VP General Counsel & Secretar | A | — | — |
| 2009-04-06 | Maninder Hora | VP Product Operations & Quali | A | — | — |
| 2009-02-24 | KURT VON EMSTER | Director | A | — | — |
| 2009-02-23 | Mark Anthony McCamish | Sr. VP & Chief Medical Officer | F | — | — |
| 2009-02-02 | Francis Willard Sarena | VP, Gen Counsel & Secy | F | — | — |
| 2009-01-27 | Bradford S Goodwin | Director | A | — | — |
| 2009-01-27 | Mark Anthony McCamish | Sr. VP & Chief Medical Officer | A | — | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the FACT quote page; the site-wide leaderboard is on the insider transactions hub.